NextConsensus Decision review

Managed decision review

For pharma access or launch decisions that need a real review now.

NextConsensus helps pharma teams turn one timing-sensitive decision into a brief they can circulate. It brings the evidence, business impact, reviewers, open questions, and options into one document before the issue drifts for another quarter.

Best fit Pharma access or launch review

Built for market access, HEOR, launch, medical, and brand teams facing one current decision they cannot keep delaying.

What comes back One brief made to circulate

The brief puts the evidence, business impact, reviewers, open questions, and options in one place.

What the brief has to make clear

The brief should make the decision easy to understand.

A strong first brief tells the team what is being asked, why it matters, who needs to weigh in, and what could change the recommendation.

Decision-brief anatomy What a pharma team needs on one page
Current evidence

What the team could reasonably rely on now, with the source trail intact.

Commercial stake

Why waiting is expensive enough to justify a real internal review now.

Who needs to weigh in

Which reviewers, functions, or committees need to weigh in before the team can move.

What could change the call

What would make the team narrow, stop, or revisit the recommendation if the facts shift.

Decision standard Move faster without making a blind call.

Good early action still leaves room to challenge the recommendation, narrow it, or stop if the facts change.

Before you share anything sensitive

The handling rules should be simple and visible.

You should know what to send first, what waits for secure handoff, and how conflicts are handled.

First-party intake Start with a short secure note.

Send the decision, who owns it, why it matters now, what is in the way, and a work email. Sensitive detail can wait.

Conflict handling NextConsensus does not take both sides of the same active decision.

If sponsor-side work and institution-side review would collide on the same call, one side is declined, paused, or separated.

Full details Read the trust page if you want the full handling details.

See what belongs in the first note, what waits for secure handoff, and how role conflicts are handled.

Search entry points

Start from the page closest to your situation.

Use these hubs if your team is starting from a broader policy question or from a cardiorenal example set.

Broader buyer problems Decision-review pages for guideline, coverage, policy, and discharge questions.

Use the broader hub when the issue is a live healthcare review problem but not yet tied to one clinical example page.

Deepest current example set Cardiorenal pages for discharge, SGLT2, finerenone, RAAS, and CKD pathway review.

Use the cardiorenal hub when the team is already searching through heart-failure or CKD examples and needs a clearer decision brief.

Next step

Read the sample brief first. If it looks useful, send a short note.

Most first conversations do not need PHI, patient records, or a long intake form. Start high-level and keep the first note simple.